Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

Inozyme Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	4,739	3,956	4,190	4,928	3,484
Other Revenue	-	-	-	1.73	30.12
Revenue	4,739	3,956	4,190	4,929	3,514
Revenue Growth (YoY)	19.80%	-5.57%	-15.01%	40.27%	16.79%
Cost of Revenue	4,621	3,819	4,039	4,721	3,378
Gross Profit	118.82	136.75	150.87	208.51	136.38
Selling, General & Admin	41.71	14.21	15.54	20.46	3.96
Other Operating Expenses	54.6	77.37	52.67	67.9	40.91
Operating Expenses	115.76	108.56	83.95	108.24	54.07
Operating Income	3.07	28.19	66.92	100.27	82.31
Interest Expense	-40.17	-41.95	-25.4	-18.13	-23.18
Interest & Investment Income	-	48.74	26.33	20.09	24.29
Currency Exchange Gain (Loss)	-	-0.04	-4.49	0.39	0.04
Other Non Operating Income (Expenses)	98.12	18.5	-3.26	-2.24	-0.44
Pretax Income	61.02	53.43	60.1	100.37	83.01
Income Tax Expense	20.78	6.59	22.39	34.82	17.87
Net Income	40.24	46.84	37.71	65.55	65.14
Net Income to Common	40.24	46.84	37.71	65.55	65.14
Net Income Growth	-14.09%	24.20%	-42.47%	0.62%	12.44%
Shares Outstanding (Basic)	28	25	25	24	23
Shares Outstanding (Diluted)	28	25	25	24	23
Shares Change (YoY)	10.39%	-0.26%	5.84%	2.95%	-
EPS (Basic)	1.43	1.84	1.48	2.72	2.79
EPS (Diluted)	1.43	1.84	1.48	2.72	2.79
EPS Growth	-22.17%	24.52%	-45.59%	-2.36%	12.44%
Free Cash Flow	44.49	-37.16	-23.25	-17.03	25.98
Free Cash Flow Per Share	1.59	-1.46	-0.91	-0.71	1.11
Gross Margin	2.51%	3.46%	3.60%	4.23%	3.88%
Operating Margin	0.07%	0.71%	1.60%	2.03%	2.34%
Profit Margin	0.85%	1.18%	0.90%	1.33%	1.85%
Free Cash Flow Margin	0.94%	-0.94%	-0.56%	-0.34%	0.74%
EBITDA	22.51	45.17	82.66	120.15	91.51
EBITDA Margin	0.47%	1.14%	1.97%	2.44%	2.60%
D&A For EBITDA	19.45	16.98	15.74	19.88	9.2
EBIT	3.07	28.19	66.92	100.27	82.31
EBIT Margin	0.07%	0.71%	1.60%	2.03%	2.34%
Effective Tax Rate	34.05%	12.34%	37.25%	34.69%	21.53%
Revenue as Reported	4,838	4,026	4,217	4,954	3,554
Advertising Expenses	-	1.71	2.56	3.89	1.59

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.